Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men.
Dong L, Lajkosz K, Sanchez-Salas R, Kuk C, Xu W, Tiwari RV, Dias Dos Santos CP, Qian H, Wang J, Dong B, Pan J, Zhu Y, Liu Q, Chan A, Kwong JCC, Woon DTS, Nesbitt M, Erlich A, Kulkarni GS, Perlis N, Hamilton RJ, Klotz L, Wallis CJD, Nguyen DD, Macek P, Tay KJ, Huang H, Toi A, Finelli A, Fleshner NE, Cheng CWS, Cathelineau X, van der Kwast TH, Xue W, Zlotta AR. Dong L, et al. Among authors: kulkarni gs. J Natl Compr Canc Netw. 2024 Nov 15;22(10):e247061. doi: 10.6004/jnccn.2024.7061. J Natl Compr Canc Netw. 2024. PMID: 39546889
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Non-Muscle-Invasive Bladder Cancer.
Villegas E, Lajkosz K, Din S, Kuk C, Chan A, Kwong JCC, Vitug C, Gao B, Hemminki O, Kot D, Misurka J, Black P, Jewett M, Soloway MS, Roupret M, Compérat E, Sweet J, Seisen T, Fleshner NE, Wrana J, van der Kwast TH, Kulkarni GS, Zlotta AR. Villegas E, et al. Among authors: kulkarni gs. J Urol. 2024 Oct 29:101097JU0000000000004305. doi: 10.1097/JU.0000000000004305. Online ahead of print. J Urol. 2024. PMID: 39470318
Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines.
Mousa A, Nguyen DD, Lalani AK, Satkunasivam R, Aminoltejari K, Hird A, Roy S, Morgan SC, Malone S, Kokorovic A, Lavallée LT, Huynh M, Shayegan B, Jiang DM, Gotto G, Breau RH, Kulkarni GS, Zlotta A, Wallis CJD. Mousa A, et al. Among authors: kulkarni gs. Cancer. 2025 Jan 1;131(1):e35606. doi: 10.1002/cncr.35606. Epub 2024 Oct 13. Cancer. 2025. PMID: 39396120 Free PMC article.
Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis.
Marcq G, Kool R, Dragomir A, Kulkarni GS, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Alimohamed N, Izawa J, Jeldres C, Rendon R, Shayegan B, Siemens R, Black PC, Cury FL, Kassouf W. Marcq G, et al. Among authors: kulkarni gs. J Clin Oncol. 2024 Oct 3:JCO2302718. doi: 10.1200/JCO.23.02718. Online ahead of print. J Clin Oncol. 2024. PMID: 39361935
Effect of Complete Transurethral Resection on Oncologic Outcomes After Radiation Therapy for Muscle-Invasive Bladder Cancer.
Avolio PP, Kool R, Shayegan B, Marcq G, Black PC, Breau RH, Kim M, Busca I, Abdi H, Dawidek M, Uy M, Fervaha G, Cury FL, Sanchez-Salas R, Alimohamed N, Izawa J, Jeldres C, Rendon R, Siemens R, Kulkarni GS, Kassouf W. Avolio PP, et al. Among authors: kulkarni gs. Int J Radiat Oncol Biol Phys. 2024 Aug 24:S0360-3016(24)03292-9. doi: 10.1016/j.ijrobp.2024.08.036. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39186955 Free article.
The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer.
Halstuch D, Kool R, Marcq G, Breau RH, Black PC, Shayegan B, Kim M, Busca I, Abdi H, Dawidek MT, Uy M, Fervaha G, Cury FL, Alimohamed NS, Jeldres C, Rendon R, Brimo F, Siemens DR, Kulkarni GS, Kassouf W, Izawa JI. Halstuch D, et al. Among authors: kulkarni gs. J Urol. 2024 Nov;212(5):710-719. doi: 10.1097/JU.0000000000004160. Epub 2024 Jul 25. J Urol. 2024. PMID: 39051515
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.
Necchi A, Roumiguié M, Kamat AM, Shore ND, Boormans JL, Esen AA, Lebret T, Kandori S, Bajorin DF, Krieger LEM, Niglio SA, Uchio EM, Seo HK, de Wit R, Singer EA, Grivas P, Nishiyama H, Li H, Baranwal P, Van den Sigtenhorst-Fijlstra M, Kapadia E, Kulkarni GS. Necchi A, et al. Among authors: kulkarni gs. Lancet Oncol. 2024 Jun;25(6):720-730. doi: 10.1016/S1470-2045(24)00178-5. Epub 2024 May 10. Lancet Oncol. 2024. PMID: 38740030 Clinical Trial.
227 results